The myofibroblast is the predominant plasminogen activator inhibitor-1-expressing cell type in human breast carcinomas.
about
Clonogenic growth of human breast cancer cells co-cultured in direct contact with serum-activated fibroblasts.TGF-β Negatively Regulates CXCL1 Chemokine Expression in Mammary Fibroblasts through Enhancement of Smad2/3 and Suppression of HGF/c-Met Signaling MechanismssiRNA against plasminogen activator inhibitor-1 ameliorates bleomycin-induced lung fibrosis in ratsInhibition of plasminogen activator inhibitor-1 binding to endocytosis receptors of the low-density-lipoprotein receptor family by a peptide isolated from a phage display library.Prognostic value of plasminogen activator inhibitor-1 in head and neck squamous cell carcinoma.Matrix metalloproteinase 13 is induced in fibroblasts in polyomavirus middle T antigen-driven mammary carcinoma without influencing tumor progression.PAI-1 Regulates the Invasive Phenotype in Human Cutaneous Squamous Cell Carcinoma.Unimpeded skin carcinogenesis in K14-HPV16 transgenic mice deficient for plasminogen activator inhibitor.Matrix remodeling stimulates stromal autophagy, "fueling" cancer cell mitochondrial metabolism and metastasis.Live-cell imaging of tumor proteolysis: impact of cellular and non-cellular microenvironmentExtracellular proteolysis in transgenic mouse models of breast cancerUnmanipulated native fat exposed to high-energy diet, but not autologous grafted fat by itself, may lead to overexpression of Ki67 and PAI-1.Knock-down of plasminogen-activator inhibitor-1 enhances expression of E-cadherin and promotes epithelial differentiation of human pancreatic adenocarcinoma cells.3D/4D functional imaging of tumor-associated proteolysis: impact of microenvironment.Characteristics of the level-of-evidence-1 disease forecast cancer biomarkers uPA and its inhibitor PAI-1.Significance of myofibroblasts in oral squamous cell carcinoma.Biomechanics of TGFβ-induced epithelial-mesenchymal transition: implications for fibrosis and cancerKrüppel-Like Factor 4 Inhibits the Transforming Growth Factor-β1-Promoted Epithelial-to-Mesenchymal Transition via Downregulating Plasminogen Activator Inhibitor-1 in Lung Epithelial CellsTissue inhibitor of matrix metalloproteinase-1 expression in colorectal cancer liver metastases is associated with vascular structures.The miR-143/-145 cluster regulates plasminogen activator inhibitor-1 in bladder cancerPAI-1 mediates the TGF-beta1+EGF-induced "scatter" response in transformed human keratinocytes.Spontaneous lung and lymph node metastasis in transgenic breast cancer is independent of the urokinase receptor uPAR.DNA Methylation Profiles of Protease Nexin 1 (SERPINE2) Gene in Human Cell Lines.PAI-1 is a Critical Upstream Regulator of the TGF-beta1/EGF-Induced Invasive Phenotype in Mutant p53 Human Cutaneous Squamous Cell Carcinoma.SERPINE1 expression discriminates site-specific metastasis in human melanomaTGF-beta1-Induced Expression of the Poor Prognosis SERPINE1/PAI-1 Gene Requires EGFR Signaling: A New Target for Anti-EGFR Therapy.Expression of plasminogen activator inhibitor-1, urokinase receptor and laminin gamma-2 chain is an early coordinated event in incipient oral squamous cell carcinoma.Assessment of the Cancer Risk of the Fat-Grafted Breast in a Murine Model.Primed atypical ductal hyperplasia-associated fibroblasts promote cell growth and polarity changes of transformed epithelium-like breast cancer MCF-7 cells via miR-200b/c-IKKβ signaling.AMP-activated protein kinase inhibits transforming growth factor-beta-induced Smad3-dependent transcription and myofibroblast transdifferentiation.Epigenetic alterations of the SERPINE1 gene in oral squamous cell carcinomas and normal oral mucosa.Lack of association between level of Plasminogen Activator Inhibitor-1 and estimates of tumor angiogenesis in early breast cancer
P2860
Q24810282-8961EF40-84DF-486B-ADC3-4F9975605005Q28547113-882CF0CC-A3CF-4000-8784-D8706242D863Q28582042-9AC62DBD-8F90-4B09-90D9-237397347B8BQ33248476-C306311F-4A68-490F-BFF4-4287DF564B6FQ33266265-6538BA79-9B11-4BF1-B746-5250A016AF7BQ33359599-2442A6D1-358D-4628-A1EA-8F5009DAB086Q33693105-DB6EC452-E4A2-47F9-B8EC-21E68D6CD383Q34887726-C8FBF61B-B23F-4309-9B50-9352DB3611B8Q35159014-92FFEF81-BFFA-4293-AF8E-DF386DCEE38FQ35597185-1C2AEBFA-FB4B-44AE-ABA5-3A1659D0BAEBQ35677095-221AA471-BB2A-4849-8B43-969B457040EFQ35752791-7E579AE8-B646-476F-9013-DB716B83724BQ36311530-971940A6-7DF2-454E-B08E-37BE4CABAB7CQ37353288-7EFB5A44-A0CB-4098-9F78-B3807F8E9278Q37801943-AD4F5F4F-ADAA-4BC9-A0C3-0814978B14DCQ37845923-A4AB4E51-3611-4EEC-A9E6-679FE4EDCFF0Q38237390-42D0DBA0-972B-43E1-AD0F-D3CEF4EF5A14Q38797076-37DE567B-0658-4FEC-A887-D23C5FED701DQ38919372-71F30B2A-8612-4CD9-983C-1CE37D78A05AQ39438731-47999D6A-6A35-45CE-9AD5-F66ABA7A7C9BQ39709591-0B8938B9-1B48-48EE-81CF-3AA4CB1CEAB8Q40872425-D84813EE-A1DC-486E-87DA-4F8CC2695C3EQ41638376-EDD698BE-44A3-4B34-8725-0D7852D3AF70Q41857137-D1B6AEBB-0C8C-4E36-8D16-07C269F20647Q42049845-45B8D1D4-1217-41B9-8581-3696A0373548Q43146931-74C88B81-CA89-4F66-A438-5DC1005836C5Q46881566-14D536D1-43F0-4E44-94CB-822D8A6695CEQ47923765-D04A83B3-F42C-483C-8355-F3AC898D7A43Q49646730-3FC3FDA6-F78B-4F6A-9E9A-771755DA7399Q53500309-5961E19B-EBF7-4D13-93C9-23AE7B4A2333Q54437518-BF4DA151-62F7-479F-9F57-E93220DEB26CQ57581296-12345D15-2CA9-445F-A843-9F4980335235
P2860
The myofibroblast is the predominant plasminogen activator inhibitor-1-expressing cell type in human breast carcinomas.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
The myofibroblast is the predo ...... pe in human breast carcinomas.
@en
type
label
The myofibroblast is the predo ...... pe in human breast carcinomas.
@en
prefLabel
The myofibroblast is the predo ...... pe in human breast carcinomas.
@en
P2093
P2860
P1476
The myofibroblast is the predo ...... pe in human breast carcinomas.
@en
P2093
Birgitte Vrou Offersen
Boye Schnack Nielsen
Fritz Rank
Gunilla Høyer-Hansen
Jens Overgaard
Peter A Andreasen
P2860
P304
P356
10.1016/S0002-9440(10)63547-X
P407
P577
2003-11-01T00:00:00Z